Test Price
1,500 AED✅ Home Collection Available
EGFR Mutational Analysis Test in UAE | 1500 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Molecular Pathology (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval from your referring hospital pathology department (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance with a DHA-licensed Specialist for actionable result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 – streamlined pre‑approval.
Test Overview & Methodology
The EGFR Mutational Analysis precisely identifies activating and resistance mutations in the epidermal growth factor receptor gene from formalin‑fixed paraffin‑embedded (FFPE) tumour tissue. This comprehensive profiling guides targeted lung cancer therapy and is performed under strict DHA‑mandated quality controls at DNA Labs UAE.
| Feature | Our EGFR Comprehensive Profiling | Closest Alternative (Basic Hotspot qPCR Panel) |
|---|---|---|
| Methodology | PCR Amplification + Fragment Length Analysis + Sanger Sequencing | Real-Time PCR (allele‑specific) only |
| Mutation Coverage | Exons 18–21, T790M, exon 20 insertions, rare mutations | Common exon 19 deletions and L858R only |
| Analytical Sensitivity | 99.9% at 1% mutant allele frequency | ~95% at 5% allele frequency |
| Turnaround Time | 5 working days (Standard courier submission) | 7–10 working days typical |
| UAE Regulatory Accreditation | ISO 9001:2015, DHA Facility License 1143 | Varies; often lacks full ISO certification |
| Price | 1,500 AED | 1,200 – 1,800 AED (often not all-inclusive) |
Physician Insight & Safety Protocols
“As a DHA‑licensed Specialist in Diagnostic Radiology, I rely on comprehensive EGFR genotyping to match patients with the most effective targeted therapy. Please remember: this test result must be interpreted in the full context of your histopathology, imaging, and clinical status. Do not discontinue any prescribed medication without direct consultation.”
Mr. Prabhakar Reddy Kalathoor (Specialist Diagnostic Radiology, DHA License: 61713011)
Medication Safety Advisory
⚠️ Never stop or modify your cancer treatment based on a single molecular result. Always discuss therapeutic decisions with your treating oncologist.
Safety & Exclusion Criteria
- Excluded samples: Tumour tissue with less than 10% malignant cell content; decalcified specimens; necrotic or inadequately fixed tissue.
- Mandatory documentation: Duly filled NGS Test Requisition Form (Form 40) and a copy of the histopathology report.
- Emergency Red Flags: If you develop acute breathlessness, severe chest pain, massive haemoptysis, or neurological symptoms, seek Emergency Department care immediately.
Patient FAQ & Clinical Guidance
1. What does a positive EGFR mutation test mean for my lung cancer treatment?
Indicates eligibility for targeted tyrosine kinase inhibitors, offering a more precise treatment with often fewer side effects than conventional chemotherapy. Your oncologist uses this information to select a first‑line EGFR‑TKI such as osimertinib or erlotinib, which directly targets the mutated protein. Confirmatory biopsy and imaging are still required to finalize the therapeutic plan.
2. Can this test be performed on a blood sample instead of a tissue block?
This validated protocol uses FFPE tumour tissue to achieve 99.9% sensitivity; liquid biopsy may miss low-allele‑frequency mutations and is not interchangeable. However, if tissue is unavailable, discuss circulating tumour DNA (ctDNA) testing with your oncologist. Tissue remains the gold standard for initial EGFR profiling in the UAE.
3. Is fasting required before the sample is collected?
No fasting is required, as the sample is an archival formalin‑fixed paraffin‑embedded (FFPE) tissue block already stored at your referring hospital. Our secure medical courier service will retrieve the block directly from the hospital pathology department. Please have your histopathology report and completed requisition form ready.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Confidentiality: DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic and clinical data are encrypted, access-controlled, and processed solely for diagnostic purposes.
Clinical Safety & Consent: Patient consent and clinical safety protocols comply with Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring full disclosure of test limitations and risks before sample processing.
Clinical & Logistical Metadata
| Test Name | EGFR Mutational Analysis (Comprehensive) |
| Price (AED) | 1,500 |
| Turnaround Time | 5 Working Days |
| Sample Type / Matrix | Formalin-Fixed Paraffin-Embedded (FFPE) Tumour Block / Archival Tissue |
| Methodology Used | PCR Amplification + Fragment Length Analysis + Sanger Sequencing |
| ICD-10-CM Code | C34.9 |
| LOINC Code | 21631-8 |
| DHA Facility License & Address | License: 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians